Browse studies

Find your next paid study

27,300 recruiting studies available now

A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (Atigotatug+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplat…

Extensive-Stage Small Cell Lung Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Bristol-Myers SquibbNCT06646276

Phase 2

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iter…

Breast Cancer Survivorship

Estimated

~$75 – $2,000

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT06478589

Phase 2

Subcutaneous Tranexamic Acid in Nasal Mohs Local Flap Reconstruction: Perioperative Bleeding, Edema, and Ecchymosis

This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs recon…

Postoperative BleedingSkin Cancer Face

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT06057675

Observational

Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery Via Primary Care

The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation. Participants will be randomly assigned to receive either…

Smoking Cessation

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical University of South CarolinaNCT05493254

Phase 2

A Multi-Center, Phase II, Open Label, Randomized Trial Evaluating the Efficacy and Safety of Complement 5a Receptor Antagonist Avacopan in Crescentic IgA Nephropathy

The purpose of this study is to evaluate the efficacy and safety of Avacopan together with low-dose glucocorticoid in the treatment of patients with crescentic…

IgA Nephropathy (IgAN)

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT06676579

Phase 1

A Multi-Site Break Through Cancer Pilot Study Testing the Feasibility and Safety of Therapeutic Intervention for Patients With High-risk Clonal Cytopenia of Undetermined Significance (CCUS)

This research is being done to find out more about the potential risks and benefits of early treatment in participants with high risk Clonal Cytopenia of Unkno…

Clonal Cytopenia of Undetermined SignificanceCytopenia

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Lachelle D. Weeks, MD, PhDNCT06802146

Phase 1

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

The proposed study will assess the combined effect of perampanel and ketamine on the anti-depressant response in individuals with treatment resistant depressio…

Depressive Disorder, MajorPost Traumatic Stress Disorder

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Yale UniversityNCT05915013

Observational

Safety and Feasibility of the MyokinE100 System in ICU Settings to Mitigate ICU Acquired Weakness

The goal of this clinical trial is to learn if a new medical device that sends electrical signals to the thigh muscles is safe and easy to use for people in th…

SepsisCritical IllnessICU-acquired Muscle Weakness+4 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Health Discovery LabsNCT07362862

Observational

Duke Customized Aortic Aneurysm Repair With Endovascular Stent-grafts - Duke CARES Trial

The purpose of this study is to see if physician modified endovascular grafts (PMEG) can be used safely for the treatment of aortic disorders. The surgeon will…

Aortic Disorders

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Chandler Long, MDNCT07064460

Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy

The purpose of this study is to compare change in pelvic floor symptoms between patients receiving medical therapy for weight loss and surgical treatment for w…

Lower Urinary Tract SymptomsStress Urinary IncontinenceUrge Urinary Incontinence+6 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Hartford HealthCareNCT07175805

Phase 1

Clinical Evaluation of the Origin Intubation System

There are currently two options that are utilized are artificial airways in the operating room as well in emergency medicine: the endotracheal tube and the sup…

Device Usability

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Stanford UniversityNCT07189182

Phase 3

A Phase 3, Open Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Combination With Lenalidomide Versus Rituximab in Combination With Lenalidomide in Relapsed/Refractory Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

This study is researching an experimental drug called odronextamab (referred to as study drug), in combination with lenalidomide. The study is focused on parti…

Relapsed/Refractory Follicular LymphomaRelapsed/Refractory Marginal Zone Lymphoma (R/R MZL)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT06149286